1![Acute Hepatitis C in the PROUD pilot study Juan Tiraboschi, Liz Brodnicki, Brady Michael, John Saunders, Schembri Gabriel, Mark Roche, Julie Fox on behalf of the PROUD study Acute Hepatitis C in the PROUD pilot study Juan Tiraboschi, Liz Brodnicki, Brady Michael, John Saunders, Schembri Gabriel, Mark Roche, Julie Fox on behalf of the PROUD study](https://www.pdfsearch.io/img/36508563a6412911fbc37cd4d1b2b5e7.jpg) | Add to Reading ListSource URL: www.proud.mrc.ac.ukLanguage: English - Date: 2017-07-17 12:33:31
|
---|
2![PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno](https://www.pdfsearch.io/img/540970e05eb0bde3b687d57f7dbe1cdb.jpg) | Add to Reading ListSource URL: www.abbvie.caLanguage: English - Date: 2018-07-18 19:08:19
|
---|
3![PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes ](https://www.pdfsearch.io/img/8334935f67d4305ddc5de1d6d841b3f3.jpg) | Add to Reading ListSource URL: www.abbvie.caLanguage: English - Date: 2018-07-18 04:02:55
|
---|
4![Contact PD/PI: Braithwaite, Ronald Scott A. SPECIFIC AIMS Many persons with HIV have Hepatitis C (HCV) co-infection and consume alcohol.1,2 Now that highly effective and easily tolerated therapies for HCV are available, Contact PD/PI: Braithwaite, Ronald Scott A. SPECIFIC AIMS Many persons with HIV have Hepatitis C (HCV) co-infection and consume alcohol.1,2 Now that highly effective and easily tolerated therapies for HCV are available,](https://www.pdfsearch.io/img/2a44b93162921777f9bc1b6e70c5c8b2.jpg) | Add to Reading ListSource URL: medicine.yale.eduLanguage: English - Date: 2017-10-26 03:35:18
|
---|
5![PRESS RELEASE AbbVie’s TECHNIVIE™ Receives Health Canada Approval for Genotype 4 Chronic Hepatitis C Infection TECHNIVIE provides an opportunity to treat adults who have genotype 4 (GT4) chronic hepatitis C PRESS RELEASE AbbVie’s TECHNIVIE™ Receives Health Canada Approval for Genotype 4 Chronic Hepatitis C Infection TECHNIVIE provides an opportunity to treat adults who have genotype 4 (GT4) chronic hepatitis C](https://www.pdfsearch.io/img/d1a855ecb8a5a589a9209337aae55e63.jpg) | Add to Reading ListSource URL: www.abbvie.caLanguage: English - Date: 2018-07-18 12:42:01
|
---|
6![](/pdf-icon.png) | Add to Reading ListSource URL: www.actionhepatitiscanada.caLanguage: English - Date: 2016-10-04 21:20:17
|
---|
7![PRESS RELEASE Health Canada Grants Priority Review to AbbVie’s Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6) PRESS RELEASE Health Canada Grants Priority Review to AbbVie’s Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6) ](https://www.pdfsearch.io/img/cb1c90489e59c606c1af6778a0813539.jpg) | Add to Reading ListSource URL: www.abbvie.caLanguage: English - Date: 2018-07-18 07:06:17
|
---|
8![PRESS RELEASE British Columbia Joins Other Provinces to Reimburse AbbVie’s HOLKIRATM PAK HOLKIRA PAK now reimbursed in British Columbia for patients with genotype 1 hepatitis C virus infection PRESS RELEASE British Columbia Joins Other Provinces to Reimburse AbbVie’s HOLKIRATM PAK HOLKIRA PAK now reimbursed in British Columbia for patients with genotype 1 hepatitis C virus infection](https://www.pdfsearch.io/img/6d2bc900dd7d581d368a11ae8b2b47ed.jpg) | Add to Reading ListSource URL: www.abbvie.caLanguage: English - Date: 2018-07-18 09:22:13
|
---|
9![PRESS RELEASE AbbVie’s HOLKIRATM PAK Now Reimbursed in all Four Atlantic Provinces HOLKIRA PAK now reimbursed in Nova Scotia, New Brunswick and Newfoundland and Labrador for patients with genotype 1 hepatitis C vir PRESS RELEASE AbbVie’s HOLKIRATM PAK Now Reimbursed in all Four Atlantic Provinces HOLKIRA PAK now reimbursed in Nova Scotia, New Brunswick and Newfoundland and Labrador for patients with genotype 1 hepatitis C vir](https://www.pdfsearch.io/img/0bbc6808db72ba1d73fcdddb98fc218d.jpg) | Add to Reading ListSource URL: www.abbvie.caLanguage: English - Date: 2018-07-18 07:08:17
|
---|
10![Injection drug use and comprehensive HIV and Hepatitis C prevention in rural US communities Moderator: Jeremiah Johnson, Treatment Action Group Dr. Carrie Ann Lawrence, Assistant Researcher, Indiana School of Public Heal Injection drug use and comprehensive HIV and Hepatitis C prevention in rural US communities Moderator: Jeremiah Johnson, Treatment Action Group Dr. Carrie Ann Lawrence, Assistant Researcher, Indiana School of Public Heal](https://www.pdfsearch.io/img/d9061c6d1bc095a87ae18b112b8dd475.jpg) | Add to Reading ListSource URL: www.preventionjustice.org- Date: 2017-03-21 12:41:42
|
---|